Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study

Background: The association between altered serum Vitamin D levels and schizophrenia has been an area that has evoked a recent fervor. The neurohumoral and neuro immunomodulatory functions of Vitamin D might have a role to play in understanding the causation of the disease and thus appear promising...

Full description

Saved in:
Bibliographic Details
Main Authors: Soumitra Ghosh, Bikashita Deka
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-09-01
Series:Indian Journal of Psychiatry
Subjects:
Online Access:https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_355_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206145799684096
author Soumitra Ghosh
Bikashita Deka
author_facet Soumitra Ghosh
Bikashita Deka
author_sort Soumitra Ghosh
collection DOAJ
description Background: The association between altered serum Vitamin D levels and schizophrenia has been an area that has evoked a recent fervor. The neurohumoral and neuro immunomodulatory functions of Vitamin D might have a role to play in understanding the causation of the disease and thus appear promising in the diagnostic and therapeutic frontiers of the disease. Aims and Objectives: We aimed to estimate and compare serum Vitamin D levels in drug-free cases of schizophrenia and in healthy control groups. The comparison was also made among the subgroups of positive and negative schizophrenia. Materials and Methods: The study, a hospital-based cross-sectional comparative study was carried out in the Department of Psychiatry, in a hospital in Assam over a period of 1 year. Fifty drug-free subjects of schizophrenia (Group A) diagnosed and confirmed according to International Classification of Diseases 10 were selected by consecutive sampling and 50 age and sex frequency-matched subjects (Group B) were selected from the healthy population. The cases (Group A) were divided into positive and negative groups (Group A1 and A2) based on the composite scoring of the Positive and Negative Syndrome Scale. After approval from the institutional ethics committee and obtaining written informed consent, Vitamin D levels were assessed in both groups of cases and controls and comparison was made. Results: After statistical analysis, it was seen that males were more in proportion and mostly in the age group of 20-39 years. The median Vitamin D level among the cases was 12.45 ng/mL and that among controls was 20.03 ng/mL which was statistically significant (P value .00932). Among the positive and negative schizophrenia subgroup, there was no statistically significant difference in Vitamin D levels at means of 16.54 ng/mL and 16.25 ng/Ml, respectively. The variation in Vitamin D levels in schizophrenics and the healthy population is thus discernible. Conclusion: It can be said that serum Vitamin D levels were significantly low in people with schizophrenia compared to the general population. Furthermore, it is seen that mean Vitamin D status is similar in both the groups of positive and negative schizophrenia negating the possibility of alteration of Vitamin D levels depending on the differences in symptomatology or in pathophysiology of the two groups.
format Article
id doaj-art-4394391ea1f44cfdbc1673d5225e1f90
institution Kabale University
issn 0019-5545
1998-3794
language English
publishDate 2023-09-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Psychiatry
spelling doaj-art-4394391ea1f44cfdbc1673d5225e1f902025-02-07T12:42:52ZengWolters Kluwer Medknow PublicationsIndian Journal of Psychiatry0019-55451998-37942023-09-0165995596010.4103/indianjpsychiatry.indianjpsychiatry_355_23Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative studySoumitra GhoshBikashita DekaBackground: The association between altered serum Vitamin D levels and schizophrenia has been an area that has evoked a recent fervor. The neurohumoral and neuro immunomodulatory functions of Vitamin D might have a role to play in understanding the causation of the disease and thus appear promising in the diagnostic and therapeutic frontiers of the disease. Aims and Objectives: We aimed to estimate and compare serum Vitamin D levels in drug-free cases of schizophrenia and in healthy control groups. The comparison was also made among the subgroups of positive and negative schizophrenia. Materials and Methods: The study, a hospital-based cross-sectional comparative study was carried out in the Department of Psychiatry, in a hospital in Assam over a period of 1 year. Fifty drug-free subjects of schizophrenia (Group A) diagnosed and confirmed according to International Classification of Diseases 10 were selected by consecutive sampling and 50 age and sex frequency-matched subjects (Group B) were selected from the healthy population. The cases (Group A) were divided into positive and negative groups (Group A1 and A2) based on the composite scoring of the Positive and Negative Syndrome Scale. After approval from the institutional ethics committee and obtaining written informed consent, Vitamin D levels were assessed in both groups of cases and controls and comparison was made. Results: After statistical analysis, it was seen that males were more in proportion and mostly in the age group of 20-39 years. The median Vitamin D level among the cases was 12.45 ng/mL and that among controls was 20.03 ng/mL which was statistically significant (P value .00932). Among the positive and negative schizophrenia subgroup, there was no statistically significant difference in Vitamin D levels at means of 16.54 ng/mL and 16.25 ng/Ml, respectively. The variation in Vitamin D levels in schizophrenics and the healthy population is thus discernible. Conclusion: It can be said that serum Vitamin D levels were significantly low in people with schizophrenia compared to the general population. Furthermore, it is seen that mean Vitamin D status is similar in both the groups of positive and negative schizophrenia negating the possibility of alteration of Vitamin D levels depending on the differences in symptomatology or in pathophysiology of the two groups.https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_355_23negative schizophreniapansspositive schizophreniaschizophreniavitamin d levels
spellingShingle Soumitra Ghosh
Bikashita Deka
Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
Indian Journal of Psychiatry
negative schizophrenia
panss
positive schizophrenia
schizophrenia
vitamin d levels
title Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
title_full Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
title_fullStr Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
title_full_unstemmed Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
title_short Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
title_sort relation of vitamin d levels with positive and negative symptoms of schizophrenia a hospital based cross sectional comparative study
topic negative schizophrenia
panss
positive schizophrenia
schizophrenia
vitamin d levels
url https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_355_23
work_keys_str_mv AT soumitraghosh relationofvitamindlevelswithpositiveandnegativesymptomsofschizophreniaahospitalbasedcrosssectionalcomparativestudy
AT bikashitadeka relationofvitamindlevelswithpositiveandnegativesymptomsofschizophreniaahospitalbasedcrosssectionalcomparativestudy